GRTS

Gritstone bio, Inc. (GRTS) | Rumor.io

Gritstone bio

GRTS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about GRTS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Dec 13

Gritstone bio, Inc. (GRTS) is facing a potentially contentious auction process, with some investors expressing concerns that the company may be hiding assets or undervaluing its CORAL project.
The auction process has raised questions about the valuation of GRTS' assets, including the CORAL project, which was previously funded by the government and showed promising results.
The company's decision to exclude certain assets from the auction process has sparked debate among investors, with some arguing that GRTS may be withholding valuable assets from the sale.

Generated by AI

Sentiment

Of the messages about GRTS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	74.65% +15.4
Bearish	—	—	—	25.35% -15.4

Bullish· Oct 17

Gritstone bio, Inc. (GRTS) has a strong track record of operation despite market manipulation, with successful government projects and improving trial results.
The company's promising pipelines, government awards, and scientific breakthroughs warrant a Nobel prize, indicating significant potential for growth.
GRTS is due for a final pump, with shorts needing to cover 11.37 million shares by Tuesday, potentially leading to a significant price increase.

Bearish· Dec 10

$GRTS is facing a class action lawsuit due to alleged mismanagement and scams by its former CEO Andrew Allen.
The company's Chapter 11 filing was deemed a terrible move by its former CEO, who is accused of having a huge ego and making poor decisions.
The auction process for GRTS's assets has been marred by controversy, with the company including a link to a previous bankruptcy in its court filing and bids being deemed weak and potentially funded by shady sources.

Generated by AI

Topics

Of the messages about GRTS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	21.43%
Controversies	—	—	—	14.29%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	64.29%

Announcements· Oct 15

Gritstone bio, Inc. (GRTS) announces positive interim results from its Phase 1/2 clinical trial of its mRNA-based COVID-19 vaccine candidate.
The trial showed a strong immune response in all 38 participants, with no serious adverse events reported.
GRTS plans to initiate a Phase 3 trial in the second half of 2022, pending discussions with regulatory authorities.

Technical Analysis· Oct 6

$GRTS has achieved a second price target of 2.83, up over 50% from 1.90.
The stock is setting up to form a bill flag, with potential resistance levels and a possible move to $5.
$GRTS is showing higher highs and higher lows, indicating it is not done yet, with potential targets at 2.80-2.85 and 3+.

Generated by AI

Community

Of the messages about GRTS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	28.79%
Newcomers	—	—	—	71.21%

Regulars· Oct 15

Gritstone bio, Inc. has filed for Chapter 11 bankruptcy, which may lead to its removal from the NASDAQ to the OTC.
$GRTS is expected to see a significant price increase, potentially reaching $0.10.
Gritstone bio, Inc. is a market mover, suggesting it has a significant impact on the market.

Newcomers· Oct 16

Gritstone Bio ($GRTS) is reportedly in talks for funding and has held conversations with potential bankruptcy plan sponsors, leading to a decline in its shares.
The company is said to be discussing a potential buyout or debt deal, which could lead to a significant increase in its stock price.
Gritstone Bio's earnings for 2024 showed a 29% improvement over the previous year, with a long-term growth potential of over 200% in profits.

Generated by AI

Also Discussed

Investors talking about GRTS also mention

#	Name	Attention
1	BioCryst Pharmaceuticals, Inc.BCRX	0.01%+0.01
2	Kiniksa Pharmaceuticals International, plc Class A Ordinary SharesKNSA	0%0
3	ONCT - Oncternal Therapeutics, Inc.	——
4	Roivant Sciences Ltd.ROIV	0%new
5	CVAC - CureVac N.V.	——
6	ALX Oncology Holdings Inc.ALXO	0%0
7	HARP - Harpoon Therapeutics, Inc.	——
8	Takeda Pharmaceutical Company Limited American Depositary ReceiptTAK	0%0
9	VBIV - VBI Vaccines Inc.	——
10	NGM - NGM Biopharmaceuticals, Inc.	——

Gritstone bio, Inc.

Location

Social

What share of all stock conversation is about GRTS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Dec 13

Gritstone bio, Inc. (GRTS) is facing a potentially contentious auction process, with some investors expressing concerns that the company may be hiding assets or undervaluing its CORAL project.
The auction process has raised questions about the valuation of GRTS' assets, including the CORAL project, which was previously funded by the government and showed promising results.
The company's decision to exclude certain assets from the auction process has sparked debate among investors, with some arguing that GRTS may be withholding valuable assets from the sale.

Generated by AI

Sentiment

Of the messages about GRTS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	74.65% +15.4
Bearish	—	—	—	25.35% -15.4

Bullish· Oct 17

Gritstone bio, Inc. (GRTS) has a strong track record of operation despite market manipulation, with successful government projects and improving trial results.
The company's promising pipelines, government awards, and scientific breakthroughs warrant a Nobel prize, indicating significant potential for growth.
GRTS is due for a final pump, with shorts needing to cover 11.37 million shares by Tuesday, potentially leading to a significant price increase.

Bearish· Dec 10

$GRTS is facing a class action lawsuit due to alleged mismanagement and scams by its former CEO Andrew Allen.
The company's Chapter 11 filing was deemed a terrible move by its former CEO, who is accused of having a huge ego and making poor decisions.
The auction process for GRTS's assets has been marred by controversy, with the company including a link to a previous bankruptcy in its court filing and bids being deemed weak and potentially funded by shady sources.

Generated by AI

Topics

Of the messages about GRTS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	21.43%
Controversies	—	—	—	14.29%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	64.29%

Announcements· Oct 15

Gritstone bio, Inc. (GRTS) announces positive interim results from its Phase 1/2 clinical trial of its mRNA-based COVID-19 vaccine candidate.
The trial showed a strong immune response in all 38 participants, with no serious adverse events reported.
GRTS plans to initiate a Phase 3 trial in the second half of 2022, pending discussions with regulatory authorities.

Technical Analysis· Oct 6

$GRTS has achieved a second price target of 2.83, up over 50% from 1.90.
The stock is setting up to form a bill flag, with potential resistance levels and a possible move to $5.
$GRTS is showing higher highs and higher lows, indicating it is not done yet, with potential targets at 2.80-2.85 and 3+.

Generated by AI

Community

Of the messages about GRTS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	28.79%
Newcomers	—	—	—	71.21%

Regulars· Oct 15

Gritstone bio, Inc. has filed for Chapter 11 bankruptcy, which may lead to its removal from the NASDAQ to the OTC.
$GRTS is expected to see a significant price increase, potentially reaching $0.10.
Gritstone bio, Inc. is a market mover, suggesting it has a significant impact on the market.

Newcomers· Oct 16

Gritstone Bio ($GRTS) is reportedly in talks for funding and has held conversations with potential bankruptcy plan sponsors, leading to a decline in its shares.
The company is said to be discussing a potential buyout or debt deal, which could lead to a significant increase in its stock price.
Gritstone Bio's earnings for 2024 showed a 29% improvement over the previous year, with a long-term growth potential of over 200% in profits.

Generated by AI

Gritstone bio

Social

Dec 13

Sentiment

Bullish· Oct 17

Bearish· Dec 10

Topics

Announcements· Oct 15

Technical Analysis· Oct 6

Community

Regulars· Oct 15

Newcomers· Oct 16

Also Discussed

Gritstone bio, Inc.

Company Information

Location

Also Discussed

Social

Dec 13

Sentiment

Bullish· Oct 17

Bearish· Dec 10

Topics

Announcements· Oct 15

Technical Analysis· Oct 6

Community

Regulars· Oct 15

Newcomers· Oct 16